| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALHC | Common Stock | Award | $0 | +2,543,124 | +93% | $0.000000 | 5,288,377 | 04 Mar 2025 | Direct | F1 |
| transaction | ALHC | Common Stock | Sale | $8,614,693 | -554,713 | -10% | $15.53 | 4,733,664 | 06 Mar 2025 | Direct | F2, F3 |
| holding | ALHC | Common Stock | 2,183,100 | 04 Mar 2025 | See Footnote | F4 |
| Id | Content |
|---|---|
| F1 | Represents shares of common stock that were acquired upon the certification by the Compensation Committee of the Alignment Healthcare, Inc. Board of Directors of the achievement of the performance objectives under performance share units ("PSUs") granted on September 14, 2023. The PSUs were scheduled to vest only if and to the extent that certain performance objectives (health plan revenue growth percentage, at-risk returning member medical benefit ratio and adjusted EBITDA, less capital expenditures) met or exceeded specified targets. In the aggregate, the performance objectives were achieved above target. Fifty percent (50%) of the granted PSUs were fully vested on the reported date of acquisition and fifty percent (50%) will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date. |
| F2 | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This transaction does not represent a discretionary trade by the reporting person. |
| F3 | The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.12 to $16.065. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |
| F4 | Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. |